ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,463Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 625

$639K Total Retail Price of All Prescriptions

Rank: 118 out of 625

415 Patients Receiving at Least One Drug in Part D
95%Patients 65 Years and Older
19% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 11,171 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
METOPROLOL SUCCINATE 1,060 1,050 1 15
ATORVASTATIN CALCIUM 802 764 2 9
AMLODIPINE BESYLATE 441 427 3 1
FUROSEMIDE 435 435 4 7
TRAMADOL HCL 356 336 5 16
SIMVASTATIN 326 326 6 2
METOPROLOL TARTRATE 308 305 7 11
LEVOTHYROXINE SODIUM 301 288 8 3
RAMIPRIL 289 282 9 78
ENALAPRIL MALEATE 271 259 10 81
OMEPRAZOLE 228 216 11 6
CRESTOR 217 207 12 17
DIOVAN 203 203 13 28
WARFARIN SODIUM 193 193 14 20
METFORMIN HCL 186 181 15 10
LISINOPRIL 186 173 15 5
HYDROCHLOROTHIAZIDE 181 169 17 12
ZOLPIDEM TARTRATE 178 177 18 13
LIPITOR 171 165 19 75
CLOPIDOGREL 158 158 20 30
DIGOXIN 126 126 21 55
KLOR-CON M20 126 126 21 47
NIASPAN 124 124 23 101
ISOSORBIDE MONONITRATE ER 123 123 24 49
PLAVIX 119 119 25 43
ESCITALOPRAM OXALATE 118 118 26 67
TRICOR 116 105 27 118
PRAVASTATIN SODIUM 112 110 28 8
POTASSIUM CHLORIDE 103 103 29 19
GLYBURIDE 96 84 R 30 106
PREDNISONE 94 93 31 37
GABAPENTIN 94 94 31 14
SYNTHROID 89 89 33 39
PANTOPRAZOLE SODIUM 86 86 34 44
ZETIA 83 83 35 66
RANITIDINE HCL 82 82 36 25
ALLOPURINOL 81 81 37 29
TOPROL XL 78 78 38 313
ATENOLOL 77 64 39 22
LOSARTAN POTASSIUM 76 76 40 18
HYDROXYZINE HCL 73 60 R 41 176
CITALOPRAM HBR 73 71 41 24
CAPTOPRIL 70 70 43 251
SPIRONOLACTONE 66 66 44 64
NEXIUM 65 62 45 21
FENOFIBRATE 64 63 46 59
FLUTICASONE PROPIONATE 64 64 46 32
CARVEDILOL 61 61 48 23
BENAZEPRIL HCL 61 61 48 35
LEXAPRO 59 59 50 196
VENLAFAXINE HCL ER 56 56 51 86
NITROSTAT 56 55 51 202
AZITHROMYCIN 53 52 53 40
COUMADIN 52 52 54 285
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 26, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.